Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Wed, 19 Jun 2019 08:03:19 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Increased BARDA Award and Option Exercise ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000198146-en Tue, 18 Jun 2019 12:00:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000198146-en <![CDATA[RNS press release - Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019 ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000197265-en Wed, 12 Jun 2019 12:00:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000197265-en <![CDATA[RNS press release - Notice of First Quarter Results ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000196271-en Wed, 05 Jun 2019 14:00:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000196271-en <![CDATA[RNS press release - UK Annual Report and Notice of AGM ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000192706-en Tue, 14 May 2019 17:30:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000192706-en <![CDATA[RNS press release - Block Listing Interim Review ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000190026-en Mon, 29 Apr 2019 12:30:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000190026-en <![CDATA[RNS press release - Exercise of Restricted Stock Units ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000179186-en Wed, 24 Apr 2019 16:20:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000179186-en <![CDATA[RNS press release - Summit Presents In Vivo Proof of Concept Data for New Mechanism Antibiotics Targeting Enterobacteriaceae in Oral Session at ECCMID 2019 ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000177816-en Mon, 15 Apr 2019 07:00:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000177816-en <![CDATA[RNS press release - Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000176021-en Wed, 03 Apr 2019 12:00:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000176021-en <![CDATA[RNS press release - Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000175675-en Tue, 02 Apr 2019 12:00:00 +0100 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000175675-en <![CDATA[RNS press release - Award of Share Options ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000155268-en Fri, 29 Mar 2019 17:45:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000155268-en <![CDATA[RNS press release - Filing of Annual Report on Form 20-F ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000155118-en Fri, 29 Mar 2019 11:15:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000155118-en <![CDATA[RNS press release - Final Results ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000154580-en Wed, 27 Mar 2019 11:00:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000154580-en <![CDATA[RNS press release - Notice of Results ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000154137-en Mon, 25 Mar 2019 11:00:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000154137-en <![CDATA[RNS press release - Summit Therapeutics to Present at Upcoming Conferences ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000152799-en Mon, 18 Mar 2019 11:00:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000152799-en <![CDATA[RNS press release - Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria Gonorrhoeae and ESKAPE Pathogens at Novel Antimicrobials and AMR Diagnostics 2019 Conference ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000152451-en Thu, 14 Mar 2019 11:00:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000152451-en <![CDATA[RNS press release - Summit’s SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical Data ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000149429-en Mon, 25 Feb 2019 12:00:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000149429-en <![CDATA[RNS press release - Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole for C. Difficile Infection ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000147881-en Wed, 13 Feb 2019 12:00:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000147881-en <![CDATA[RNS press release - Summit Therapeutics to Present at the BIO CEO & Investor Conference ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000147215-en Fri, 08 Feb 2019 12:00:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000147215-en <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000144181-en Tue, 15 Jan 2019 17:45:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000144181-en <![CDATA[RNS press release - Award of Restricted Stock Units ]]> https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000143969-en Mon, 14 Jan 2019 12:00:00 +0000 https://www.proactiveinvestors.co.uk/LON:SUMM/Summit-Therapeutics-PLC/rns/NASDAQ_1000143969-en